[Strategies of the nasal mucous membranes for defense against infection. Current knowledge of antimicrobial peptides]
- PMID: 15798924
- DOI: 10.1007/s00106-005-1232-3
[Strategies of the nasal mucous membranes for defense against infection. Current knowledge of antimicrobial peptides]
Abstract
Infections of healthy skin or mucous membranes are rare despite constant exposure to microbial colonization. Nonspecific and specific defense mechanisms correspond in the nose: the mucociliary clearance provides very effective mechanical cleaning. If this protection is insufficient, the nasal epithelium comes into close contact with microorganisms. This triggers the recently discovered production of the body's own specific antimicrobial peptides (AP). It seems that it is difficult for microorganisms to form enzyme-induced resistance to AP. This makes AP highly interesting for the development of new antibiotics. The observation that antimicrobial activity can be induced has also led to the hypothesis that natural substances may possibly stimulate endogenous AP production. If this line of defense also fails, the inflammatory cells migrate from the blood into the tissue and, with their capacity for phagocytosis, the enzymatic attack on bacteria can cause a cellular inflammatory reaction in the nasal mucous membrane.
Similar articles
-
Host defense peptides for use as potential therapeutics.Curr Opin Investig Drugs. 2009 Feb;10(2):164-71. Curr Opin Investig Drugs. 2009. PMID: 19197794 Review.
-
Antimicrobial peptides versus invasive infections.Curr Top Microbiol Immunol. 2006;306:111-52. doi: 10.1007/3-540-29916-5_5. Curr Top Microbiol Immunol. 2006. PMID: 16909920 Review.
-
Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease.Acta Otolaryngol. 2003 Jan;123(1):81-5. doi: 10.1080/0036554021000028089. Acta Otolaryngol. 2003. PMID: 12625579
-
Potential therapeutic application of host defense peptides.Methods Mol Biol. 2010;618:303-27. doi: 10.1007/978-1-60761-594-1_19. Methods Mol Biol. 2010. PMID: 20094872
-
[Effector molecules of the innate immune system for treatment of wound infections].Chirurg. 2007 Apr;78(4):343-8. doi: 10.1007/s00104-007-1314-8. Chirurg. 2007. PMID: 17377758 Review. German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources